No Data
No Data
Takeda-backed Ascentage Pharma Files for $100M IPO
Sector Update: Health Care Stocks Mixed Pre-Bell Friday
Takeda Gains Approval For HYQVIA In Japan To Treat Immunodeficiency
TD Cowen Maintains Takeda Pharmaceutical(TAK.US) With Buy Rating
Teva Pharmaceutical Releases Impressive Phase 2 Candidate Data For Gastro-Related Diseases
Takeda Pharmaceutical (TAK.US) CD38 monoclonal antibody has been approved for clinical use again in China.
Takeda Pharmaceutical's CD38 monoclonal antibody has been approved for clinical use in China again.